Skip to content
Open access

No time to waste: Evaluation of diagnostic delays in vulvar cancer.

Aug 2026 · Gynecologic Oncology · Vol 212, pp. 43-49 · 0 citations · 28 references
Medicine

TL;DR

Delayed diagnosis of vulvar SCC was associated primarily with provider and healthcare system-related factors rather than patient or tumor characteristics, which may help facilitate more prompt diagnosis and therapeutic intervention.

Abstract

Objectives

To identify patient, provider, and system-level factors associated with delayed diagnosis of vulvar squamous cell cancer (SCC).

Methods

An IRB-approved retrospective single-institution cohort study was conducted in patients with vulvar SCC diagnosed from 2009 to 2020. Patients were compared by time from symptom onset to biopsy using a prespecified threshold of <6 months versus ≥6 months. Demographic, tumor, provider, and healthcare utilization variables were collected. Progression-free survival (PFS) and overall survival (OS) were examined.

Results

Among 157 eligible patients, 39 (24.8%) experienced a diagnostic delay of ≥6 months. Delayed diagnosis was not associated with age, race, smoking status, dermatologic conditions, tumor size, stage, insurance, or income. Patients with delayed diagnosis underwent more clinic visits, examinations, empiric therapies, and encounters before biopsy (all p ≤ 0.003). Initial provider specialty differed significantly between groups: patients diagnosed within 6 months were more likely to first present to a gynecologic provider, whereas those initially evaluated by non-gynecologic providers had longer median time to diagnosis (1.9 vs 4.7 months, p < 0.0001) and were more likely to experience delay ≥6 months (34.7% vs 16.5%, p = 0.0098). On multivariable analysis, higher BMI (aOR 1.05 per kg/m2, 95% CI 1.01-1.10) and initial evaluation by a non-gynecologic provider (aOR 2.24, 95% CI 1.03-5.01) independently predicted delay ≥6 months.

Conclusions

Delayed diagnosis of vulvar SCC was associated primarily with provider and healthcare system-related factors rather than patient or tumor characteristics. Earlier biopsy, timely gynecologic referral, and improved patient and provider education may help facilitate more prompt diagnosis and therapeutic intervention.

Read PDF

Similar papers

Review Open access Aug 2026

Factors associated with diagnostic delay among patients with oral squamous cell carcinoma: a hospital-based observational study.

Educational status, diabetic status and primary lesion site stage were significantly associated with diagnostic delay, and Multivariable regression identified educational status as an independent factor associated with total diagnostic delay.

Jacob Mathew Philip, H. Abraham · 0 citations
Open access Sep 2026

Delays to initial evaluation drive socioeconomic care disparities in endometrial cancer

The discrepancy in time to surgical management of EC was driven by delays in first provider visit, indicating that disparities are related to symptom recognition and access to initial evaluation rather than delays within specialty care.

Elizabeth Ingersent, Emma C. Donigan, Amanda L. Tapia et al. · 0 citations
Review Open access Sep 2026

Survival outcome of Gallbladder cancer in the US: An updated surveillance, epidemiology, and end results-based analysis of age and gender disparities

Male gender, older age, and distant tumor stage are significant predictors of higher mortality, while chemotherapy and surgery substantially improve survival in GBC patients, highlighting the necessity for targeted interventions and personalized treatment approaches to enhance survival rates.

Ayrton I. Bangolo, Behzad Amoozgar, B. Alqinai et al. · 0 citations
Review Open access Sep 2026

Clinicopathological Features, Treatment Modalities, and Prognostic Factors of Leptomeningeal Carcinomatosis in Patients with Breast Cancer: A Single-Center Retrospective Analysis

Aim: Leptomeningeal metastasis (LM) from breast cancer carries a poor prognosis, and most published cohorts originate from high-volume referral centers. We aimed to identify factors associated with overall survival (OS) after an LM diagnosis in routine practice and to describe diagnostic and treatment patterns.Methods:...

Mehmet Mutlu Kıdı, Omer Kaya, Sedat Biter et al. · 0 citations
Open access Sep 2026

Care delivery among patients with early-onset versus average-onset cholangiocarcinoma: a nationwide retrospective analysis

Background Cholangiocarcinoma (CCA) is an aggressive biliary malignancy with increasing incidence and poor prognosis. Although traditionally considered a disease of older adults, early-onset CCA (EOCCA; age <50 years) may represent a clinically distinct subgroup. Data evaluating diagnostic and treatment trajectories in...

U. Grewal, A. Nottke, B. Loeffler et al. · 0 citations
Open access Sep 2026

The clinicopathologic and molecular profile of second primary thyroid cancer in pediatric cancer survivors

To characterize the clinicopathological and molecular profiles, treatment, and outcomes of second primary thyroid cancer (SPTC) in childhood cancer survivors to inform risk-stratified surveillance and management. This retrospective case series enrolled patients (aged ≤18 years at thyroid cancer diagnosis)...

Yu-Wei Liu, Ai-Lei Yang, Yan-Zhen Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.